Dr. Snydman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Washington St
Box 836
Boston, MA 02111Phone+1 617-636-5788Fax+1 617-636-8525- Is this information wrong?
Summary
- Dr. David Snydman is an infectious disease specialist in Boston, MA and is affiliated with Tufts Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 45 years. He is experienced in cytomegalovirus, c.diff colitis, nosocomial infections, transplant infectious disease, and transplant infections. He has more than 300 publications and over 20,000 citations. He has been awarded the Walter Stamm mentorship award from the Infectious Disease Society of America, and received a Citation from the Commonwealth of Massachusetts for his role in the development of Cytomegalovirus Immune Globulin. He has received a Distinguished Faculty award from Tufts University School of Medicine.
Education & Training
- Tufts Medical Center1979
- Tufts Medical CenterResidency, Internal Medicine, 1974
- Perelman School of Medicine at the University of PennsylvaniaClass of 1972
- Williams CollegeB.A., Cum Laude, Highest Honors in Chemistry, 1968
Certifications & Licensure
- MA State Medical License 1976 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Americas Best Doctors Selection 2008-2016
- Walter E. Stamm Mentor Award Infectious Diseases Society of America, 2015
- Boston Magazine Castle Connolly, 2010-2015
- Join now to see all
Clinical Trials
- Probiotic Lactobacillus GG to Eliminate VRE Colonization Start of enrollment: 2003 Mar 01
- Letermovir Use in Heart Transplant Recipients Start of enrollment: 2021 Oct 01
Roles: Principal Investigator, Contact
- Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients Start of enrollment: 2023 Feb 02
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Comparative Effectiveness of Fidaxomicin vs Vancomycin in Populations With Immunocompromising Conditions for the Treatment ofInfection: A Single-Center Study.Rodday, A., Kent, D., Alsoubani, M., Chow, J., Snydman, D.> ;Open Forum Infectious Diseases. 2024 Jan 1
- A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart Transplantation.Whitney A Perry, Jennifer K Chow, Jason Nelson, David M Kent, David R Snydman> ;Transplantation Direct. 2023 Dec 1
- Sex- and age-based comparison of serum immunoglobulins following liver transplantation.Whitney A Perry, Audrey E A Martino, Marta Rodriguez Garcia, Jennifer K Chow, David R Snydman> ;Transplant Immunology. 2023 Jun 1
- Join now to see all
Journal Articles
- Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantationKotton CN, Kumar D, Caliendo AM, Asberg A, Chou S Danziger-Isakov L, Humar A; Transplantation Society International CMV Consensus Group, Transplantation, 1/1/2013
- Introduction Symposium in Honor of the Memory of Francis P Tally, MD, Held at Tufts Medical Center and Tufts University School of MedicineSnydman DR, Clinical Infectious Disease, 1/1/2010
- Symposium in Honor of the Memory of Francis P Tally, MD, Held at Tufts Medical Center and Tufts University School of Medicine, 11 June 2007Snydman DR, Clinical Infectious Disease, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- D-1151 - Antibiotic Resistance among Bacteroides spp. And Evolving Multidrug-Resistance.D.R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
- In Vitro Activity of Surotomycin Tested Against 885 Isolates of Clostridium difficile Collected as part of a National Surveillance Program 2011-2012.D.R. Snydman, L.A. McDermott, N.V. Jacobus, S.G. Jenkins, E.J.C. Goldstein, R. Patel, B.A. Forbes, S. Mirrett, D.W. Hecht, R. Goering, C. Thorpe, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
- T-2031- Cost Burden of Cytomegalovirus (CMV) Disease Among Solid Organ Transplant Recipients.H. Yang, D. Zhuo, Z. Zhou, E. Q. Wu, P. Chaudhari, D. R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
- Join now to see all
Other
- State-of-the-Art Management of CMV Infection and Disease in Transplant Recipients. CME slide kit, CD Rom, and web site for education.David R. Snydman and Robert H. Rubin, Synermed Coomunications and the Dannemiller Memorial Education Foundation
http://www.cmvlink.com
1/1/2006 - Hypogammaglobulinemia in organ transplantation 2005. A continuing education program sponsored by Tufts University.David R. Snydman, Robin K. Avery, Shira Doron, Arthur R. Rabson, Mohamad H. Yamani, Bramnick and Associates, New York, NY
1/1/2005 - Transplantation Related InfectionsSnydman DR, Tufts University School of Medicine
1/1/2000 - Join now to see all
Press Mentions
- 2015 AST FAST DesigneesMay 21st, 2015
Grant Support
- Clincal Research Training In Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2010–2011
- Probiotic Lactobacillus GG To Eliminate VRE ColonizationNational Center For Complementary &Alternative Medicine2006–2010
- Clinical Research Training In Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2005–2009
- Probiotic Lactobacillus GG To Eliminate VRE ColonizationNational Center For Research Resources2005
- Probiotic Lactobacillus GG To Eliminate VRE ColonizationNational Center For Complementary &Alternative Medicine2004–2005
- Lgg To Eliminate Intestinal Colonization By EnterococcusNational Center For Research Resources2004
- Hypogammaglobulinemia In Liver Transplant PatientsNational Center For Research Resources2004
- Pharmacokinetics, Safety And Efficacy Of Cmvig PLUS GanciclovirNational Center For Research Resources1998–1999
- Pilot Trial, Pharmacokinetics, Safety And Efficacy Of Cmvig PLUS GanciclovirNational Center For Research Resources1997
- Pilot Trial And Pharmacokinetics, Safety And Efficacy Of Cmvig PLUS GanciclovirNational Center For Research Resources1995–1996
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
- Tufts Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: